fbthumb

Los Angeles – Last week, the Los Angeles Memorial Coliseum Commission was ordered to pay Insomniac, Inc. approximately $400,000 in attorney’s fees stemming from the Commission’s failed lawsuit against Insomniac and the company’s CEO, Pasquale Rotella.

Last August 30, Superior Court Judge Terry Green dismissed all claims made by the Commission against Insomniac and Mr. Rotella, finding that despite six attempts the Commission had still failed to plead a viable case. Subsequent to the August ruling, Insomniac filed a motion to collect the attorneys’ fees that it incurred in defeating the Commission’s claims.

In response to Friday’s decision, Insomniac’s attorney, Gary Jay Kaufman, issued the following statement:

 “We are very pleased that the Court awarded Insomniac the full amount of its attorneys’ fees.  This is just further confirmation of what we have maintained from day one: this lawsuit was ill-conceived, politically motivated and publicity driven. Neither Insomniac nor Mr. Rotella did anything wrong and this lawsuit should never have been brought in the first place.”

 

About Insomniac

Insomniac produces some of the most innovative, immersive music festivals and events in the world. Enhanced by state-of-the-art lighting, pyrotechnics and sound design, large-scale art installations, theatrical performers and next generation special effects, these events captivate the senses and inspire a unique level of fan interaction. The quality of the experience is the company’s top priority.

Throughout its 20-year history, Insomniac has produced more than 250 festivals, concerts and club nights for nearly 4 million attendees in California, Colorado, Florida, Nevada, New York, Texas, Puerto Rico, and the United Kingdom. The company’s premier annual event, Electric Daisy Carnival Las Vegas, is the largest multi-day music festival in North America, and attracted more than 345,000 fans over three days in June 2013.

The company was founded by Pasquale Rotella, and has been based in Los Angeles since it was formed in 1993.